Tokyo Tape
Sign in
← J Frontier

Annual report

2934.TEDINET S100SX2D
Period2022-06-01 → 2023-05-31
Filed2024-02-21
StandardJapan GAAP
ConsolidatedYes
Data checks23 of 23 passed

Amends S100RRVE. Amended by S100SXUN (2024-02-21).

Key figures · 116
MetricValuePeriodScopeSource row
Revenue¥16.8bn2022-06-01 → 2023-05-31Cons.Net sales
Revenue¥11.9bn2021-06-01 → 2022-05-31Cons.Net sales
Operating income−¥1.8bn2022-06-01 → 2023-05-31Cons.Operating income
Operating income¥731m2021-06-01 → 2022-05-31Cons.Operating income
Ordinary income−¥1.8bn2022-06-01 → 2023-05-31Cons.Ordinary income
Ordinary income¥712m2021-06-01 → 2022-05-31Cons.Ordinary income
Profit before tax−¥1.8bn2022-06-01 → 2023-05-31Cons.Income before income taxes
Profit before tax¥700m2021-06-01 → 2022-05-31Cons.Income before income taxes
Net income (owners)−¥1.9bn2022-06-01 → 2023-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥401m2021-06-01 → 2022-05-31Cons.Profit loss attributable to owners of parent
Net income−¥1.9bn2022-06-01 → 2023-05-31Cons.Profit loss
Net income¥400m2021-06-01 → 2022-05-31Cons.Profit loss
Total assets¥7.2bnat 2023-05-31Cons.Assets
Total assets¥6.1bnat 2022-05-31Cons.Assets
Total liabilities¥4.5bnat 2023-05-31Cons.Liabilities
Total liabilities¥1.9bnat 2022-05-31Cons.Liabilities
Net assets / equity¥2.7bnat 2023-05-31Cons.Net assets
Net assets / equity¥4.2bnat 2022-05-31Cons.Net assets
Net assets / equity¥1.3bnat 2021-05-31dCons.Net assets
Cash and deposits¥1.6bnat 2023-05-31Cons.Cash and deposits
Cash and deposits¥3.0bnat 2022-05-31Cons.Cash and deposits
Cash & equivalents¥1.6bnat 2023-05-31Cons.Cash and cash equivalents
Cash & equivalents¥3.0bnat 2022-05-31Cons.Cash and cash equivalents
Cash & equivalents¥1.6bnat 2021-05-31dCons.Cash and cash equivalents
Operating cash flow−¥1.8bn2022-06-01 → 2023-05-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥367m2021-06-01 → 2022-05-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.1bn2022-06-01 → 2023-05-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥860m2021-06-01 → 2022-05-31Cons.Net cash provided by used in investment activities
Financing cash flow¥1.5bn2022-06-01 → 2023-05-31Cons.Net cash provided by used in financing activities
Financing cash flow¥2.6bn2021-06-01 → 2022-05-31Cons.Net cash provided by used in financing activities
EPS (basic)¥-410.62022-06-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥90.642021-06-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥86.682021-06-01 → 2022-05-31Cons.Diluted earnings per share (5-year summary)
Net assets per share¥525.78at 2023-05-31Cons.Net assets per share (5-year summary)
Net assets per share¥907.43at 2022-05-31Cons.Net assets per share (5-year summary)
Equity ratio34.1%at 2023-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio67.8%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
ROE9.7%2021-06-01 → 2022-05-31Cons.Rate of return on equity (5-year summary)
Employees255at 2023-05-31Cons.Number of employees
Employees278at 2022-05-31Cons.Number of employees
Revenue¥9.4bn2022-06-01 → 2023-05-31StandaloneNet sales
Revenue¥9.3bn2021-06-01 → 2022-05-31StandaloneNet sales
Revenue¥8.5bn2020-06-01 → 2021-05-31dStandaloneNet sales (5-year summary)
Revenue¥7.1bn2019-06-01 → 2020-05-31dStandaloneNet sales (5-year summary)
Revenue¥6.1bn2018-06-01 → 2019-05-31dStandaloneNet sales (5-year summary)
Operating income−¥1.7bn2022-06-01 → 2023-05-31StandaloneOperating income
Operating income¥751m2021-06-01 → 2022-05-31StandaloneOperating income
Ordinary income−¥1.7bn2022-06-01 → 2023-05-31StandaloneOrdinary income
Ordinary income¥724m2021-06-01 → 2022-05-31StandaloneOrdinary income
Ordinary income¥679m2020-06-01 → 2021-05-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥174m2019-06-01 → 2020-05-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥367m2018-06-01 → 2019-05-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.7bn2022-06-01 → 2023-05-31StandaloneIncome before income taxes
Profit before tax¥723m2021-06-01 → 2022-05-31StandaloneIncome before income taxes
Net income−¥1.7bn2022-06-01 → 2023-05-31StandaloneProfit loss
Net income¥450m2021-06-01 → 2022-05-31StandaloneProfit loss
Net income¥425m2020-06-01 → 2021-05-31dStandaloneNet income loss (5-year summary)
Net income¥96m2019-06-01 → 2020-05-31dStandaloneNet income loss (5-year summary)
Net income¥6m2018-06-01 → 2019-05-31dStandaloneNet income loss (5-year summary)
Total assets¥5.8bnat 2023-05-31StandaloneAssets
Total assets¥5.3bnat 2022-05-31StandaloneAssets
Total assets¥2.6bnat 2021-05-31dStandaloneTotal assets (5-year summary)
Total assets¥2.0bnat 2020-05-31dStandaloneTotal assets (5-year summary)
Total assets¥1.9bnat 2019-05-31dStandaloneTotal assets (5-year summary)
Total liabilities¥3.1bnat 2023-05-31StandaloneLiabilities
Total liabilities¥1.1bnat 2022-05-31StandaloneLiabilities
Net assets / equity¥2.8bnat 2023-05-31StandaloneNet assets
Net assets / equity¥4.2bnat 2022-05-31StandaloneNet assets
Net assets / equity¥1.3bnat 2021-05-31dStandaloneNet assets
Net assets / equity¥843mat 2020-05-31dStandaloneNet assets (5-year summary)
Net assets / equity¥746mat 2019-05-31dStandaloneNet assets (5-year summary)
Cash and deposits¥814mat 2023-05-31StandaloneCash and deposits
Cash and deposits¥2.4bnat 2022-05-31StandaloneCash and deposits
Cash & equivalents¥1.6bnat 2021-05-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥902mat 2020-05-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥948mat 2019-05-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥831m2020-06-01 → 2021-05-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥218m2019-06-01 → 2020-05-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥14m2018-06-01 → 2019-05-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥8m2020-06-01 → 2021-05-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥165m2019-06-01 → 2020-05-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥63m2018-06-01 → 2019-05-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥94m2020-06-01 → 2021-05-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥99m2019-06-01 → 2020-05-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥130m2018-06-01 → 2019-05-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-357.082022-06-01 → 2023-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥101.912021-06-01 → 2022-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥110.752020-06-01 → 2021-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥25.122019-06-01 → 2020-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥1.62018-06-01 → 2019-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥97.452021-06-01 → 2022-05-31StandaloneDiluted earnings per share (5-year summary)
Net assets per share¥589.16at 2023-05-31StandaloneNet assets per share (5-year summary)
Net assets per share¥918.35at 2022-05-31StandaloneNet assets per share (5-year summary)
Net assets per share¥329.99at 2021-05-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥219.25at 2020-05-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥194.13at 2019-05-31dStandaloneNet assets per share (5-year summary)
Equity ratio47.4%at 2023-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio79.0%at 2022-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio48.8%at 2021-05-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio41.5%at 2020-05-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio39.0%at 2019-05-31dStandaloneEquity to asset ratio (5-year summary)
ROE-47.5%2022-06-01 → 2023-05-31StandaloneRate of return on equity (5-year summary)
ROE16.5%2021-06-01 → 2022-05-31StandaloneRate of return on equity (5-year summary)
ROE40.3%2020-06-01 → 2021-05-31dStandaloneRate of return on equity (5-year summary)
ROE12.2%2019-06-01 → 2020-05-31dStandaloneRate of return on equity (5-year summary)
ROE0.8%2018-06-01 → 2019-05-31dStandaloneRate of return on equity (5-year summary)
Shares issued4,892,098at 2023-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,757,616at 2022-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,918,500at 2021-05-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,918,500at 2020-05-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,918,500at 2019-05-31dStandaloneTotal number of issued shares (5-year summary)
Employees49at 2023-05-31StandaloneNumber of employees
Employees54at 2022-05-31StandaloneNumber of employees
Employees46at 2021-05-31dStandaloneNumber of employees
Employees47at 2020-05-31dStandaloneNumber of employees
Employees42at 2019-05-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 71
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2022-06-01 → 2023-05-31¥2m
Reconciling Itemsreconcilingdepreciation2022-06-01 → 2023-05-31¥765,000
Reconciling Itemsreconcilingrevenue2022-06-01 → 2023-05-31−¥186m
Reconciling Itemsreconcilingrevenue intersegment2022-06-01 → 2023-05-31−¥186m
Reconciling Itemsreconcilingsegment assetsat 2023-05-31¥1.3bn
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2023-05-31−¥729m
Healthcare Marketing Businessreportable segmentcapex2022-06-01 → 2023-05-31¥4m
Healthcare Marketing Businessreportable segmentdepreciation2022-06-01 → 2023-05-31¥5m
Healthcare Marketing Businessreportable segmentemployeesat 2023-05-3148 pure
Healthcare Marketing Businessreportable segmentrevenue2022-06-01 → 2023-05-31¥5.2bn
Healthcare Marketing Businessreportable segmentrevenue external2022-06-01 → 2023-05-31¥5.1bn
Healthcare Marketing Businessreportable segmentrevenue intersegment2022-06-01 → 2023-05-31¥185m
Healthcare Marketing Businessreportable segmentsegment assetsat 2023-05-31¥1.1bn
Healthcare Marketing Businessreportable segmentsegment profit2022-06-01 → 2023-05-31¥39m
Healthcare Sales Businessreportable segmentcapex2022-06-01 → 2023-05-31¥1.1bn
Healthcare Sales Businessreportable segmentdepreciation2022-06-01 → 2023-05-31¥4m
Healthcare Sales Businessreportable segmentemployeesat 2023-05-3148 pure
Healthcare Sales Businessreportable segmentrevenue2022-06-01 → 2023-05-31¥4.1bn
Healthcare Sales Businessreportable segmentrevenue external2022-06-01 → 2023-05-31¥4.1bn
Healthcare Sales Businessreportable segmentsegment assetsat 2023-05-31¥2.4bn
Healthcare Sales Businessreportable segmentsegment profit2022-06-01 → 2023-05-31−¥28m
Medical Care Sales Businessreportable segmentcapex2022-06-01 → 2023-05-31¥288m
Medical Care Sales Businessreportable segmentdepreciation2022-06-01 → 2023-05-31¥14m
Medical Care Sales Businessreportable segmentemployeesat 2023-05-31144 pure
Medical Care Sales Businessreportable segmentrevenue2022-06-01 → 2023-05-31¥7.7bn
Medical Care Sales Businessreportable segmentrevenue external2022-06-01 → 2023-05-31¥7.7bn
Medical Care Sales Businessreportable segmentrevenue intersegment2022-06-01 → 2023-05-31¥564,000
Medical Care Sales Businessreportable segmentsegment assetsat 2023-05-31¥2.4bn
Medical Care Sales Businessreportable segmentsegment profit2022-06-01 → 2023-05-31−¥1.1bn
—segment totalemployeesat 2023-05-31255 pure
Total Of Reportable Segments And Otherssegment totalcapex2022-06-01 → 2023-05-31¥1.4bn
Total Of Reportable Segments And Otherssegment totaldepreciation2022-06-01 → 2023-05-31¥23m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-05-31¥17.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-05-31¥16.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-06-01 → 2023-05-31¥186m
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2023-05-31¥5.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-05-31−¥1.1bn
Reconciling Itemsreconcilingcapex2021-06-01 → 2022-05-31¥5m
Reconciling Itemsreconcilingdepreciation2021-06-01 → 2022-05-31¥5m
Reconciling Itemsreconcilingrevenue2021-06-01 → 2022-05-31−¥54m
Reconciling Itemsreconcilingrevenue intersegment2021-06-01 → 2022-05-31−¥54m
Reconciling Itemsreconcilingsegment assetsat 2022-05-31¥2.7bn
Reconciling Itemsreconcilingsegment profit2021-06-01 → 2022-05-31−¥425m
Healthcare Marketing Businessreportable segmentcapex2021-06-01 → 2022-05-31¥362m
Healthcare Marketing Businessreportable segmentdepreciation2021-06-01 → 2022-05-31¥2m
Healthcare Marketing Businessreportable segmentrevenue2021-06-01 → 2022-05-31¥3.9bn
Healthcare Marketing Businessreportable segmentrevenue external2021-06-01 → 2022-05-31¥3.8bn
Healthcare Marketing Businessreportable segmentrevenue intersegment2021-06-01 → 2022-05-31¥54m
Healthcare Marketing Businessreportable segmentsegment assetsat 2022-05-31¥1.3bn
Healthcare Marketing Businessreportable segmentsegment profit2021-06-01 → 2022-05-31¥37m
Healthcare Sales Businessreportable segmentdepreciation2021-06-01 → 2022-05-31¥703,000
Healthcare Sales Businessreportable segmentrevenue2021-06-01 → 2022-05-31¥3.0bn
Healthcare Sales Businessreportable segmentrevenue external2021-06-01 → 2022-05-31¥3.0bn
Healthcare Sales Businessreportable segmentsegment assetsat 2022-05-31¥251m
Healthcare Sales Businessreportable segmentsegment profit2021-06-01 → 2022-05-31¥779m
Medical Care Sales Businessreportable segmentcapex2021-06-01 → 2022-05-31¥588m
Medical Care Sales Businessreportable segmentdepreciation2021-06-01 → 2022-05-31¥3m
Medical Care Sales Businessreportable segmentrevenue2021-06-01 → 2022-05-31¥5.0bn
Medical Care Sales Businessreportable segmentrevenue external2021-06-01 → 2022-05-31¥5.0bn
Medical Care Sales Businessreportable segmentsegment assetsat 2022-05-31¥1.9bn
Medical Care Sales Businessreportable segmentsegment profit2021-06-01 → 2022-05-31¥339m
Total Of Reportable Segments And Otherssegment totalcapex2021-06-01 → 2022-05-31¥950m
Total Of Reportable Segments And Otherssegment totaldepreciation2021-06-01 → 2022-05-31¥5m
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2022-05-31¥11.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2022-05-31¥11.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-06-01 → 2022-05-31¥54m
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2022-05-31¥3.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2022-05-31¥1.2bn
Healthcare Marketing Businessreportable segmentemployeesat 2023-05-3110 pure
Healthcare Sales Businessreportable segmentemployeesat 2023-05-3119 pure
Medical Care Sales Businessreportable segmentemployeesat 2023-05-318 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,468
ItemContextValueUnit
Net assetsPrior1YearInstant4163534000JPY
Net assetsCurrentYearInstant2714794000JPY
Liabilities and net assetsPrior1YearInstant6099295000JPY
Liabilities and net assetsCurrentYearInstant7240548000JPY
Net salesPrior1YearDuration11876681000JPY
Net salesCurrentYearDuration16844572000JPY
Cost of salesPrior1YearDuration6477461000JPY
Cost of salesCurrentYearDuration9727926000JPY
Gross profitPrior1YearDuration5399220000JPY
Gross profitCurrentYearDuration7116646000JPY
Selling general and administrative expensesPrior1YearDuration4668068000JPY
Selling general and administrative expensesCurrentYearDuration8933130000JPY
Operating incomePrior1YearDuration731151000JPY
Operating incomeCurrentYearDuration-1816484000JPY
Interest income noiPrior1YearDuration29000JPY
Interest income noiCurrentYearDuration502000JPY
Dividends income noiPrior1YearDuration84000JPY
Dividends income noiCurrentYearDuration1000JPY
Subsidy income noi bountyPrior1YearDuration388000JPY
Subsidy income noi bountyCurrentYearDuration4438000JPY
Insurance premiums refunded cancellation noiPrior1YearDuration5696000JPY
Insurance premiums refunded cancellation noiCurrentYearDuration40000JPY
Other noiPrior1YearDuration4694000JPY
Other noiCurrentYearDuration1960000JPY
Non operating incomePrior1YearDuration10893000JPY
Non operating incomeCurrentYearDuration6943000JPY
Interest expenses noePrior1YearDuration1449000JPY
Interest expenses noeCurrentYearDuration11109000JPY
Stock issuance cost noePrior1YearDuration25778000JPY
Stock issuance cost noeCurrentYearDuration－JPY
Share acquisition rights issuance costs noePrior1YearDuration－JPY
Share acquisition rights issuance costs noeCurrentYearDuration9384000JPY
Provision of allowance for doubtful accounts noePrior1YearDuration1088000JPY
Provision of allowance for doubtful accounts noeCurrentYearDuration928000JPY
Provision for loss on litigation noePrior1YearDuration－JPY
Provision for loss on litigation noeCurrentYearDuration3593000JPY
Other noePrior1YearDuration1998000JPY
Other noeCurrentYearDuration6642000JPY
Non operating expensesPrior1YearDuration30315000JPY
Non operating expensesCurrentYearDuration31658000JPY
Ordinary incomePrior1YearDuration711729000JPY
Ordinary incomeCurrentYearDuration-1841199000JPY
Gain on reversal of subscription rights to shares eiPrior1YearDuration2000JPY
Gain on reversal of subscription rights to shares eiCurrentYearDuration－JPY
Extraordinary incomePrior1YearDuration2000JPY
Extraordinary incomeCurrentYearDuration－JPY
Loss on retirement of noncurrent assets elPrior1YearDuration1448000JPY
Loss on retirement of noncurrent assets elCurrentYearDuration5657000JPY
Loss on sales of investment securities elPrior1YearDuration9854000JPY
Loss on sales of investment securities elCurrentYearDuration－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 23 of 23 passed
balance sheet identityconsolidated 2022-05-31pass rounding
balance sheet identityconsolidated 2023-05-31pass rounding
balance sheet identitynon_consolidated 2022-05-31pass rounding
balance sheet identitynon_consolidated 2023-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net assetsconsolidated 2023-05-31pass
statement vs summary · net assetsnon_consolidated 2021-05-31pass
statement vs summary · net assetsnon_consolidated 2022-05-31pass
statement vs summary · net assetsnon_consolidated 2023-05-31pass
statement vs summary · net income attributable to parentconsolidated 2021-06-01/2022-05-31pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2023-05-31pass
statement vs summary · operating cash flowconsolidated 2021-06-01/2022-05-31pass
statement vs summary · operating cash flowconsolidated 2022-06-01/2023-05-31pass
statement vs summary · revenueconsolidated 2021-06-01/2022-05-31pass
statement vs summary · revenueconsolidated 2022-06-01/2023-05-31pass
statement vs summary · revenuenon_consolidated 2021-06-01/2022-05-31pass
statement vs summary · revenuenon_consolidated 2022-06-01/2023-05-31pass
statement vs summary · total assetsconsolidated 2022-05-31pass
statement vs summary · total assetsconsolidated 2023-05-31pass
statement vs summary · total assetsnon_consolidated 2022-05-31pass
statement vs summary · total assetsnon_consolidated 2023-05-31pass